铁和高氧性肺损伤:对病理生理学和治疗方法的洞察
Xiaoqiong Zhou1, Lei Tian2, Wenyan Xiong3
1Department of Anesthesiology, Zigong First People's Hospital, Zigong Academy of Medical Sciences, Zigong, China.
Frontiers in pharmacology
|April 2, 2025
概括
过氧治疗可以导致肺损伤,但铁死提供了新的治疗见解. 本综述探讨了铁灭的机制和改善高氧性肺损伤 (HLI) 治疗安全性的策略.
科学领域:
- 肺部医学 肺部医学
- 细胞死亡研究 细胞死亡研究
- 毒理学 毒理学 毒理学
背景情况:
- 过氧治疗至关重要,但可能导致肺损伤.
- 过氧性肺损伤 (HLI) 的机制尚未完全理解.
- 目前的HLI治疗方法有限,需要提高安全性.
研究的目的:
- 审查ferroptosis在HLI病变发生中的作用.
- 分析当前和新兴的针对HLI. ferroptosis的治疗战略.
- 将研究成果从实验室连接到HLI的临床应用.
主要方法:
- 关于铁和HLI的文献综述.
- 对涉及HLI机制中的铁化研究的分析.
- 针对HLI中的铁亡的治疗策略的综合.
主要成果:
- 铁,标志着铁的积累和脂质过氧化,有助于HLI.
- HLI涉及扩散的膜损伤,血管损伤和支气管肺功能障碍通过铁死.
- 新兴的疗法向铁灭,以减轻HLI.
结论:
- 铁亡是高氧性肺损伤的一个关键机制.
- 向铁灭症为HLI提供了一个有希望的治疗途径.
- 进一步的研究可以将基于铁灭的治疗方法转化为临床实践,以获得更安全的过氧治疗.
相关概念视频
Necrosis
3.7K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
131
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
131
Acute Respiratory Failure-II
151
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
151
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Flail Chest-II
148
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
148


